Abstract: Chagas disease is caused by the protozoan Trypanosoma cruzi and is widely distributed throughout Latin America. Because it is a pathology neglected by the pharmaceutical industry and because existing drugs have low efficacy and several side effects, interest in new drugs has been increasing. Due to the necessity of the discovery of new structures, the objective of this work was to relate the biological activity of natural and semi-synthetic aromatic compounds, inhibitors of glyceraldehyde 3-phosphate dehydrogenase enzyme, with descriptors calculated by molecular modeling, such as HOMO-LUMO frontier orbitals, partition coefficient (LogP) and water solubility (LogS), in addition to performing a molecular docking study, in order to obtain a better molecular view of the interaction of the aromatic compounds with the active site of the enzyme. It was observed that the compounds involved in the study interacted attractively with the enzyme, in accordance with experimental studies, and had adequate solubility for good pharmacokinetics. It was also possible to relate the pharmacological activity of some compounds with the energy of the LUMO orbital. The study showed that the methodology used in this work can be used to understand the interaction of active compounds with their respective targets, saving time and resources. __________________________________________________________________________________ Keywords: Chagas disease, molecular docking, molecular modeling, aromatic compounds Graphical Abstract:
Introduction:
Chagas disease is an infectious process caused by the protozoan Trypanosoma cruzi, which in turn is transmitted to humans through triatomine insects commonly known as "barbers" [1] [2] [3] .
A number of natural and synthetic compounds have been highlighted because they present high pharmacological activity against T.
cruzi, through the inhibition of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a glycolytic enzyme responsible for the conversion of glyceraldehyde-3-phosphate to 1,3 -diphosphoglycerate and which has structural differences with respect to the human enzyme.
The infective forms of T. cruzi are dependent on the glycolytic pathway, which makes the enzyme a promising target for the creation of antichagasic drugs, since the inhibition of GAPDH will cause the inhibition of the T. cruzi glycolytic pathway [4, 5] . [6] , and chalepin, which is a synthetic coumarin derivative [10] (Figure 1 ). 
Materials and Methods:

Calculation of molecular descriptors
All structures of the ligands were drawn through ChemSketch 11.0. The molecular optimization and calculations of the frontier molecular orbitals of the compounds, were performed by quantum mechanics using the semi-empirical method PM7, with software MOPAC7 [20] .
The ALOGPS 2.1 software was used for calculations of partition coefficient (log P) and water solubility (log S) of the compounds [21] ALOGPS 2.1 predicts the partition coefficient (log P) and water solubility (log S) of the compounds [21] [22] [23] [24] [25] .
Molecular Docking Study
The crystallographic structure of the Results and Discussion:
Molecular Descriptors
In relation to the octanol / water partition coefficient (LogP) calculated by ALOGPS 2.1, the values found for compounds 1-6 can be visualized in Table 1 . It can be observed that guajaverin and quercetin, compounds with higher experimental IC 50 values (Figure 1) , among the target compounds of the present study, were the compounds that presented the lowest logP value, which suggests that, even more soluble in organic solvents, the compounds have less efficiency in the permeability in hydrophobic biological barriers, when compared to Other target compounds of the present study. [31] .
In order to predict the electronic characteristics of compounds 1-6, the boundary molecular orbitals (HOMO and LUMO) were calculated by the semi-empirical quantum method PM7 ( Table 2) It can be observed that triliroside, the compound with the highest inhibitory activity of the enzyme GAPDH, showed the lowest energy of LUMO orbital, which indicates that its stability to the active site can occur by the interaction of the LUMO of the triliroside with HOMO orbital of the enzyme. Table 3 shows the results obtained through the docking study between compounds 1-6 with the enzyme glyceraldehyde 3-phosphate dehydrogenase [33] . 
Conclusions:
The computational study carried out in this work allowed a better view, at a molecular level, regarding the interaction of compounds [1] [2] [3] [4] [5] [6] with the enzyme, showing that the compounds that have lower IC 50 also have more stable energy of drug-receptor binding. This result suggests that there is a more selective mechanism of interaction in GAPDH.
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